Delisting riskPopularity #3,846
HRTX · NASDAQ · Biotechnology

Heron Therapeutics (HRTX)

Sells U.S. hospital injectables for postsurgical pain and nausea prevention.

$0.2943
vs last close−0.00 (−1.57%)